Name
Osaühing Baltic Medical Partners
Registry code
10169214
VAT number
EE100184321
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
18.02.1997 (27)
Financial year
01.01-31.12
Capital
2 556.00 €
Activity
86231 - Provision of dental treatment
554 024 €
19 455 €
4%
2 065 €
(estimate is approximate)
75 274 €
7
Submitted
No tax arrears
26%
12%
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Tallinna Hambaravi OÜ 16330587 | 100% - 2 556.00 EUR | - | - | |
| Meelis Eelmäe 11.05.1973 (51) | - | Board member | Member of a higher management body, i.e. board member or supervisory board member | |
| Rimo Hunt 05.11.1985 (38) | - | Board member | Member of a higher management body, i.e. board member or supervisory board member |
| 2019 24.06.2020 | 2020 18.06.2021 | 2021 30.06.2022 | 2022 13.06.2023 | 2023 14.06.2024 | |
|---|---|---|---|---|---|
| Total Revenue | 336 812 € | 348 922 € | 310 941 € | 506 615 € | 554 024 € |
| Net profit (loss) for the period | -72 € | 17 878 € | -5 315 € | 18 492 € | 19 455 € |
| Profit Margin | -0% | 5% | -2% | 4% | 4% |
| Current Assets | 28 819 € | 68 351 € | 59 521 € | 76 704 € | 110 684 € |
| Fixed Assets | 15 460 € | 12 470 € | 8 132 € | 55 595 € | 49 612 € |
| Total Assets | 44 279 € | 80 821 € | 67 653 € | 132 299 € | 160 296 € |
| Current Liabilities | 19 515 € | 38 179 € | 30 326 € | 76 480 € | 85 022 € |
| Non Current Liabilities | - | - | - | - | - |
| Total Liabilities | - | - | - | - | - |
| Share Capital | - | - | - | - | - |
| Equity | 24 764 € | 42 642 € | 37 327 € | 55 819 € | 75 274 € |
| Employees | 6 | 6 | 5 | 6 | 7 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 390.67 € | 21 246.41 € | 22 294.12 € | 8 |
| 2023 Q4 | 531.23 € | 22 733.96 € | 23 596.29 € | 9 |
| 2023 Q3 | 288.3 € | 19 124.53 € | 19 989.27 € | 9 |
| 2023 Q2 | 532.3 € | 20 988.04 € | 21 859.32 € | 9 |
| 2023 Q1 | 606.77 € | 18 545.46 € | 19 060.66 € | 8 |
| 2022 Q4 | 382.75 € | 15 680.18 € | 16 297.42 € | 7 |
| 2022 Q3 | 370.27 € | 14 262.76 € | 14 860.54 € | 7 |
| 2022 Q2 | - | 22 291.07 € | 23 215.64 € | 7 |
| 2022 Q1 | - | 18 851.84 € | 19 699.43 € | 8 |
| 2021 Q4 | - | 14 801.17 € | 15 426.55 € | 9 |
| 2021 Q3 | - | 16 057.58 € | 16 883.02 € | 8 |
| 2021 Q2 | - | 14 371.09 € | 15 089.97 € | 8 |
| 2021 Q1 | - | 14 130.82 € | 14 839.61 € | 8 |
| 2020 Q4 | - | 15 533.03 € | 16 356.79 € | 8 |
| 2020 Q3 | - | 12 406.15 € | 13 036.11 € | 8 |
| 2020 Q2 | - | 9 676.34 € | 10 272.66 € | 8 |
| 2020 Q1 | - | 14 509.17 € | 15 364.53 € | 9 |
